Target intelligence / Profile preview

Collagen synthesis pathway enzyme (null)

Target
null
Molecular classification
Enzyme, Oxidoreductase (for prolyl and lysyl hydroxylases), Glycosyltransferase (for glycosylation enzymes)
01

Overview

Collagen synthesis pathway enzymes refer collectively to the group of intracellular enzymes responsible for the post-translational modifications required for proper collagen biosynthesis. The most critical among these are **prolyl 4-hydroxylases**, **prolyl 3-hydroxylases**, and **lysyl hydroxylases**. These enzymes catalyze the hydroxylation of specific proline and lysine residues in procollagen chains within the endoplasmic reticulum. This modification is essential for stabilizing the triple-helical structure of collagen molecules through hydrogen bonding and facilitating subsequent glycosylation events[1][2][3][4][5]. Hydroxylysines also serve as sites for further glycosylation by galactosyltransferases. After secretion into the extracellular space, additional processing occurs via proteolytic cleavage by procollagen peptidases to form mature tropocollagen[9]. Cross-linking between tropocollagens is mediated by lysyl oxidase. Defects or dysregulation in these enzymes can result in connective tissue disorders such as Ehlers-Danlos syndrome or contribute to pathological fibrosis and tumor metastasis due to abnormal extracellular matrix remodeling[2]. **Note:** "Collagen synthesis pathway enzymes" is not a single molecular target but rather a functional group comprising several distinct but related enzymatic proteins involved in collagen biosynthesis. For structured data purposes, it would be more accurate to specify individual targets such as "Prolyl 4-hydroxylase" or "Lysyl hydroxylase," each with their own gene/protein identifiers (e.g., P4HA1/PLOD1)[1][2][3].

Other names
Collagen biosynthesis enzymeCollagen-modifying enzymeProlyl hydroxylaseLysyl hydroxylaseProcollagen-lysine 2-oxoglutarate 5-dioxygenaseMatrix metalloproteinase (for degradation phase)
02

Mechanism of action

Inhibition of enzymatic activity to reduce collagen cross-linking or stability[2]

03

Biological functions

Post-translational modificationExtracellular matrix organizationProtein folding and maturation
04

Disease associations

Connective tissue disordersCancer metastasisFibrosis
05

Safety considerations

Impaired wound healing with inhibition
06

Interacting drugs

None specific; some inhibitors of prolyl hydroxylases are under investigation for fibrotic diseases and cancer[2]
07

Biomarkers

Hydroxyproline levels (as a marker of collagen turnover)

Beyond the preview

Go deeper on Collagen synthesis pathway enzyme (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen synthesis pathway enzyme (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call